Heaton Named Fellow by American Pharmacists Association
Pam Heaton, PhD, is to be recognized with the distinction of fellow at the American Pharmacists Association (APhA) 2018 Awards and Honors Program March 16-19 in Nashville, Tennessee.
The APhA awards and honors program is the most comprehensive recognition program in the profession of pharmacy. Fellows are either members of the APhA Academy of Pharmacy Practice and Management or the APhA Academy of Pharmaceutical Research and Science with a minimum of 10 years professional experience. To become a fellow, members must have demonstrated exemplary professional achievements and service to the profession through activities with APhA and other national, state or local professional organizations.
Heaton is chair and professor of pharmacy practice and administrative sciences at the James L. Winkle College of Pharmacy. She teaches a required pharmacy ethics course in the doctor of pharmacy curriculum. She also trains graduate students in the area of health outcomes. Her current research focus is on the use of secondary databases to evaluate clinical, humanistic and economic outcomes of drug therapy. She has published over 60 manuscripts and given over 100 poster presentations.
In partnership with Kroger Pharmacy, Heaton has developed a two-year MS/residency with an emphasis in community pharmacy. Also, with Kroger Pharmacy, along with the Cincinnati Health Council, Health Bridge and several hospitals, Heaton received a grant from National Association of Chain Drug Stores to determine whether community pharmacists can reduce 30-day readmissions for patients with priority conditions.
She is an associate editor for the Journal of the American Pharmacists Association and led the development of its first community residency issue.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.